Epidermal Growth Factor Receptor Antagonist [EPC] - N0000175664

Pharmacologic Class Information

Pharmacologic Code N0000175664
Pharmacologic Name Epidermal Growth Factor Receptor Antagonist
Pharmacologic Uses
  • epidermal growth factor receptor (EGFR) antagonist
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Epidermal Growth Factor Receptor Antagonist

The table contains 5 products whose active ingredient are classified under the same pharmacologic class Epidermal Growth Factor Receptor Antagonist [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0002-7716Portrazza Non-Proprietary Name: NecitumumabSolutionIntravenousEli Lilly And CompanyACTIVE
55513-954Vectibix Non-Proprietary Name: PanitumumabSolutionIntravenousAmgen IncACTIVE
55513-956Vectibix Non-Proprietary Name: PanitumumabSolutionIntravenousAmgen IncACTIVE
66733-948Erbitux Non-Proprietary Name: CetuximabSolutionIntravenousImclone LlcACTIVE
66733-958Erbitux Non-Proprietary Name: CetuximabSolutionIntravenousImclone LlcACTIVE